`
`th NOVARTIS
`
`Global Regulatory CMC
`
`RFBOO2
`0.5 mg/0.05 mL
`Solution for injection in pre-filled syringe
`@xs
`a
`7008027_P2_MB_967_5.”
`ce
`
`Pharmaceutical Devé opment
`
`LS
`Ss
`o
`&S
`Author: a~“KS
`Date:
`1 6-Aug-20%9
`@)
`Replaces:
`Toos0geP2M9674
`Reasonfor revision: upg of information on silicone oil emulsion
`Number of pages:
`-.62
`weA
`
`Property of Novartis
`Confidential
`Maynot be used, divulged, published or otherwise disclosed
`without the consent of Novartis
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`NOVITC(CH)00004818
`Novartis Exhibit 2120.001
`Regeneron v. Novartis, IPR2021-00816
`
`Novartis Exhibit 2120.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`Regeneron v. Novartis, IPR2021-00816
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER—NOVITC(CH)00004818
`Novartis Exhibit 2120.002
`
`Novartis Exhibit 2120.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.009
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0010
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0011
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0012
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0013
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0014
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`
`
`SLOO'OZIZHAIYXYSHIBAON
`
`
`
`
`
`91800-IZOTUdI‘SHIBAON“AUOIOUaSOY
`
`SNIVLNOO
`81870000(HD)OLIAONYACHOSAILOALONdOLLOAPANS‘NOILVWYOSNISSANISNEWILNAGISNODSNIVLNOO
`
`
`
`
`
`
`
`Regeneron v. Novartis, IPR2021-00816
`Novartis Exhibit 2120.0015
`
`
`
`
`
`91800-1Z07UdI‘SHJVAON‘AUOIOUASOY
`
`
`
`
`
`
`
`9100OICHAIYXHSHIBAON
`
`SNIVLNOO NOILVINHOANI
`81840000(HO)O.LIAONYACHOFAILOALOYdOLLOAPENS‘NOILVWYOANISSANISNETWILNAGIANOS
`
`
`
`
`
`
`Regeneron v. Novartis, IPR2021-00816
`Novartis Exhibit 2120.0016
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0017
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0018
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0019
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0020
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0021
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0022
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0023
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0024
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0025
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0026
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`SNIVLNOO
`8L870000(HD)OLIAONYACHOSAILOALOYdOLLOALANS‘NOILVINYOSNISSANISNGTIWILNSCISNODSNIVLNOO
`
`
`
`
`
`
`
`Novartis Exhibit 2120.0027
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0028
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0029
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0030
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0031
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0032
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0033
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0034
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0035
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0036
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0037
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0038
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0039
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0040
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0041
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0042
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0043
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0044
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0045
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0046
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0047
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0048
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0049
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0050
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0051
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0052
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0053
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0054
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0055
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0056
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0057
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0058
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0059
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0060
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0061
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0062
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0063
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0064
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0065
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0066
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0067
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0068
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0069
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0070
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0071
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0072
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0073
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0074
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0075
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0076
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0077
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0078
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0079
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0080
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0081
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION
`
`NOVITC(CH)00004818
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`Novartis Exhibit 2120.0082
`Regeneron v. Novartis, IPR2021-00816
`
`